AnalystsLaura ChicoLaura Chico's Stock Forecasts
AnalystsLaura Chico
Analyst Ranking
Bottom 2%
#4332 out of 4414 analysts
Average Return
-25.58%
Win Rate
22%17 out of 78
Risk vs Reward
Poor
Good
Laura Chico's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Stoke Therapeutics IncSTOK | +119.38% | $27.61 | $60.57 | 2019-12-18 - 2020-12-18 | Buy |
Chinook Therapeutics IncKDNY | +74.32% | $23.13 | $40.32 | 2023-05-10 - 2023-08-08 | Buy |
Xenon Pharmaceuticals IncXENE | +59.29% | $11.25 | $17.92 | 2020-03-25 - 2021-03-25 | Buy |
Pepgen IncPEPG | +41.02% | $11.19 | $15.78 | 2022-05-31 - 2023-05-30 | Buy |
Viridian Therapeutics IncVRDN | +31.84% | $12.50 | $16.48 | 2023-10-31 - 2023-11-29 | Buy |
Laura Chico Analyst Color
Get additional color on Laura Chico's coverage of popular stocks
Laura Chico's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dianthus Therapeutics IncDNTH | 1 | Buy | $23.00 | +98.11% | Initiates Coverage On | 9 days ago |
Karuna Therapeutics IncKRTX | 3 | Buy | $253.00 | +34.16% | Reiterates | 14 days ago |
Vigil Neuroscience IncVIGL | 4 | Buy | $23.00 | +618.75% | Reiterates | 14 days ago |
Edgewise Therapeutics IncEWTX | 5 | Buy | $23.00 | +267.41% | Maintains | 21 days ago |
Rallybio CorpRLYB | 2 | Buy | $14.00 | +614.29% | Maintains | 21 days ago |
Xenon Pharmaceuticals IncXENE | 5 | Buy | $46.00 | +36.30% | Maintains | 22 days ago |
Biogen IncBIIB | 10 | Hold | $239.00 | +2.99% | Maintains | 22 days ago |
Sage Therapeutics IncSAGE | 4 | Hold | $22.00 | +12.94% | Maintains | 23 days ago |
Denali Therapeutics IncDNLI | 4 | Buy | $31.00 | +68.57% | Reiterates | 23 days ago |
Pharvaris NvPHVS | 2 | Buy | $24.00 | +38.65% | Maintains | a month ago |
Viridian Therapeutics IncVRDN | 4 | Buy | $37.00 | +124.51% | Maintains | a month ago |
Astria Therapeutics IncATXS | 4 | Buy | $18.00 | +288.77% | Maintains | 2 months ago |
Longboard Pharmaceuticals IncLBPH | 3 | Buy | $11.00 | +198.91% | Reiterates | 2 months ago |
Praxis Precision Medicines IncPRAX | 4 | Hold | $30.00 | +72.12% | Reiterates | 2 months ago |
Travere Therapeutics IncTVTX | 5 | Buy | $12.00 | +87.79% | Reiterates | 2 months ago |
Neurocrine Biosciences IncNBIX | 5 | Buy | $137.00 | +20.66% | Maintains | 3 months ago |
Ardelyx IncARDX | 5 | Buy | $7.00 | +60.18% | Reiterates | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 8 | Hold | $29.00 | -42.35% | Reiterates | 3 months ago |
Design Therapeutics IncDSGN | 4 | Hold | $6.00 | +179.07% | Downgrades | 4 months ago |
Vera Therapeutics IncVERA | 4 | Hold | $16.00 | +19.85% | Maintains | 4 months ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $42.00 | +3.99% | Downgrades | 4 months ago |
Pepgen IncPEPG | 4 | Buy | $22.00 | +373.12% | Reiterates | 6 months ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Hold | $51.00 | +30.40% | Maintains | 6 months ago |
Stoke Therapeutics IncSTOK | 4 | Buy | $25.00 | +549.35% | Maintains | 9 months ago |
Impel Pharmaceuticals IncIMPL | 2 | Hold | $5.00 | N/A | Downgrades | a year ago |
Taysha Gene Therapies IncTSHA | 2 | Buy | $5.00 | N/A | Maintains | a year ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $148.50 | N/A | Downgrades | a year ago |
Viela Bio IncVIE | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Voyager Therapeutics IncVYGR | 1 | Hold | $6.00 | N/A | Downgrades | 3 years ago |
Biomarin Pharmaceutical IncBMRN | 3 | Buy | $110.00 | N/A | Reinstates | 5 years ago |
Acer Therapeutics IncACER | 2 | Buy | $40.00 | N/A | Reinstates | 5 years ago |
Paratek Pharmaceuticals IncPRTK | 2 | Buy | N/A | N/A | Downgrades | 6 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $720.00 | N/A | Initiates Coverage On | 6 years ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.